Skip to main content
. 2022 Jan 8;14(2):308. doi: 10.3390/cancers14020308
CI Cyonfirdence interval
CK Cytokeratin
IHC Immunohistorychemistry
LL Lower limit
MICE Multivariate imputation by chained equations
MMPP Multitype marked point patterns
NND Nearest neighbor distance
pCR Pathologic complete response
PCTL Percentile
PFS Progression-free survival
TAM Tumor-associated macrophages
TIME Tumor immune microenvironment
TMA Tissue microarray
TN Tumor nest
TNBC Triple-negative breast cancer
TS Tumor stroma
UL Upper limit
UTL Upper tolerance limit